Body mass index and metabolic factors predict glomerular filtration rate and albuminuria over 20 years in a high-risk population

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Nagel, Gabriele ^a,b   Zitt, Emanuel ^c   Peter, Raphael ^a,b   Pompella, Alfonso ^d   Concin, Hans ^a   Lhotta, Karl ^c  

^a AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

^b UNIVERSITY OF ULM   (Germany)

^c Academic Teaching Hospital Feldkirch   (Austria)

^d UNIVERSITY OF PISA   (Italy)

Author keywords

Albuminuria; Body mass index; Epidemiology; Gamma glutamyltransferase; Glomerular filtration rate; Obesity

Indexed keywords

ALBUMIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; HEALTH SURVEY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR;

AGED; ALBUMINURIA; BODY MASS INDEX; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84882303898     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-177     Document Type: Article

References (37)

1. World Health Organization-Regional Office Europe, Health Topics: Obesity [ http://www.euro.who.int/en/what-we-do/health-topics/noncommunicable-diseases/ obesity ]
2. Obesity and risk for chronic renal failure. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O, J Am Soc Nephrol 2006 17 1695 1702 10.1681/ASN.2005060638 16641153 (Pubitemid 43794672)
3. Body Mass Index in 1.2 Million Adolescents and Risk for End-Stage Renal Disease. Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K, Calderon-Margalit R, Arch Intern Med 2012 172 1644 50 10.1001/2013. jamainternmed.85 23108588
4. The metabolic syndrome: a concept hard to define. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Mehta R, Franco A, Olaiz G, Rull JA, Arch Med Res 2005 36 223 231 10.1016/j.arcmed.2004.12.003 15925012 (Pubitemid 40755135)
5. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD, Clin J Am Soc Nephrol 2011 6 2364 2373 10.2215/CJN.02180311 21852664
6. Elevated serum gamma-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer-a narrative review. Targher G, Clin Chem Lab Med 2010 48 147 157 19943812
7. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Bonora E, Targher G, Nat Rev Gastroenterol Hepatol 2012 9 372 381 10.1038/nrgastro.2012.79 22565095
8. Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme. Ulmer H, Kelleher C, Diem G, Concin H, Eur Heart J 2003 24 1004 1013 10.1016/S0195-668X(03)00170-2 12788300 (Pubitemid 36712276)
9. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS, JAMA 2007 298 2038 2047 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
10. Risk models to predict chronic kidney disease and its progression: a systematic review. Echouffo-Tcheugui JB, Kengne AP, PLoS Med 2012 9 1001344 10.1371/journal.pmed.1001344 23185136
11. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Muntner P, Coresh J, Smith JC, Eckfeldt J, Klag MJ, Kidney Int 2000 58 293 301 10.1046/j.1523-1755.2000.00165.x 10886574 (Pubitemid 30429874)
12. Predictors of new-onset kidney disease in a community-based population. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D, JAMA 2004 291 844 850 10.1001/jama.291.7.844 14970063 (Pubitemid 38543772)
13. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. Kurella M, Lo JC, Chertow GM, J Am Soc Nephrol 2005 16 2134 2140 10.1681/ASN.2005010106 15901764 (Pubitemid 41716445)
14. Glycemic status and development of kidney disease: the Framingham Heart Study. Fox CS, Larson MG, Leip EP, Meigs JB, Wilson PW, Levy D, Diabetes Care 2005 28 2436 2440 10.2337/diacare.28.10.2436 16186276 (Pubitemid 41384290)
15. Association between body mass index and CKD in apparently healthy men. Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM, Am J Kidney Dis 2005 46 871 880 10.1053/j.ajkd.2005.08.015 16253727 (Pubitemid 41505461)
16. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. Bonnet F, Marre M, Halimi JM, Stengel B, Lange C, Laville M, Tichet J, Balkau B, J Hypertens 2006 24 1157 1163 10.1097/01.hjh.0000226206.03560.ac 16685216 (Pubitemid 43772324)
17. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A, Kidney Int 2007 71 159 166 10.1038/sj.ki.5002017 17136030 (Pubitemid 46094690)
18. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS, Am J Kidney Dis 2008 52 39 48 10.1053/j.ajkd.2008.03.003 18440684 (Pubitemid 351853265)
19. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, Levey AS, Weiner DE, Am J Kidney Dis 2008 52 29 38 10.1053/j.ajkd.2008.02.363 18511168 (Pubitemid 351853273)
20. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Stevens PE, Levin A, Ann Intern Med 2013 158 825 830 10.7326/0003-4819-158-11- 201306040-00007 23732715
21. Association between Younger Age When First Overweight and Increased Risk for CKD. Silverwood RJ, Pierce M, Thomas C, Hardy R, Ferro C, Sattar N, Whincup P, Savage C, Kuh D, Nitsch D, J Am Soc Nephrol 2013 24 813 821 10.1681/ASN.2012070675 23559581
22. Sex differences in the relationships between BMI, WHR and incidence of cardiovascular disease: a population-based cohort study. Li C, Engstrom G, Hedblad B, Calling S, Berglund G, Janzon L, Int J Obes (Lond) 2006 30 1775 1781 10.1038/sj.ijo.0803339 (Pubitemid 44863410)
23. The metabolic syndrome. Kahn R, Buse J, Ferrannini E, Stern M, Lancet 2005 366 1921 1922 author reply 1923-1924 16325688
24. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, Circulation 2009 120 1640 1645 10.1161/CIRCULATIONAHA.109.192644 19805654
25. The metabolic syndrome. Unwin N, J R Soc Med 2006 99 457 462 10.1258/jrsm.99.9.457 16946389 (Pubitemid 44549900)
26. The metabolic syndrome and chronic kidney disease in U.S. adults. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J, Ann Intern Med 2004 140 167 174 10.7326/0003-4819-140-3-200402030-00007 14757614
27. Chronic kidney disease and metabolic syndrome in a general Korean population: the Third Korea National Health and Nutrition Examination Survey (KNHANES III) Study. Jang SY, Kim IH, Ju EY, Ahn SJ, Kim DK, Lee SW, J Public Health (Oxf) 2010 32 538 546 10.1093/pubmed/fdp127
28. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS, Arterioscler Thromb Vasc Biol 2007 27 127 133 10.1161/01.ATV. 0000251993.20372.40 17095717 (Pubitemid 46360389)
29. Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis. Liu CF, Gu YT, Wang HY, Fang NY, PLoS One 2012 7 48878 10.1371/journal.pone.0048878 23145005
30. Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Targher G, Kendrick J, Smits G, Chonchol M, Nutr Metab Cardiovasc Dis 2010 20 583 590 10.1016/j.numecd.2009.05. 012 19699624
31. Association between serum gamma-glutamyltransferase and chronic kidney disease among US adults. Teppala S, Shankar A, Li J, Wong TY, Ducatman A, Kidney Blood Press Res 2010 33 1 6 10.1159/000274463 20090360
32. gamma-Glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS, Clin Chem 2007 53 71 77 17110470 (Pubitemid 46055179)
33. Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Lee DH, Jacobs DR Jr, Gross M, Steffes M, Clin Chem 2005 51 1185 1191 10.1373/clinchem.2004.045872 15890893 (Pubitemid 43079396)
34. Associations of uric acid and gamma-glutamyltransferase (GGT) with obesity and components of metabolic syndrome in children and adolescents. Kong AP, Choi KC, Ho CS, Chan MH, Ozaki R, Chan CW, Chan JC, Pediatr Obes 2012 [Epub ahead of print] 10.1111/j.2047-6310.2012.00115.x
35. Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. Franzini M, Fornaciari I, Fierabracci V, Elawadi HA, Bolognesi V, Maltinti S, Ricchiuti A, De Bortoli N, Marchi S, Pompella A, et al. Liver Int 2012 32 629 634 10.1111/j.1478-3231.2011.02673.x 22098947
36. Is serum gamma glutamyltransferase a marker of oxidative stress? Lee DH, Blomhoff R, Jacobs DR Jr, Free Radic Res 2004 38 535 539 10.1080/ 10715760410001694026 15346644 (Pubitemid 38697087)
37. Association between serum gamma-glutamyltransferase and C-reactive protein. Lee DH, Jacobs DR Jr, Atherosclerosis 2005 178 327 330 10.1016/j.atherosclerosis.2004.08.027 15694941 (Pubitemid 40193447)